Mark Reding, MD

Mark Reding, MD
Request Appointment
Center for Bleeding and Clotting Disorders
Phillips-Wangensteen Building
Sixth Floor, Clinic 6B
516 Delaware St. SE
Minneapolis, MN 55455

Medical Title:

Academic Appointments:


Clinical Interests:

Languages Spoken:


Board Certifications:

"Best Doctors for Women" Minnesota Monthly Magazine 2013

Mpls. St. Paul Magazine
"Top Doctor" - (2012, 2014)

U.S. News & World Report 2012 Top Doctor 

Kren BT, Unger GM, Sjeklocha L, Korman V, Diethelm-Okita BM, Reding MT, Steer CJ. Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal epithelial cells of hemophilia A mice. J Clin Invest 2009 Jul; 119(7): 2086-99.

Astermark J, Lacroix-Desmazes S, Reding MT. Inhibitor development. Haemophilia 2008 Jul; 14(Suppl 3):36-42.

Elimelakh M, Dayton V, Park KS, Gruessner AC, Sutherland D, Howe RB, Reding MT, Eastlund T, van Burik JA, Singleton TP, Gruessner RW, Key NS. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica 2007; 92(8):1029-36.

Reding MT. Immunological aspects of inhibitor development. Haemophilia 2006 Dec; 12(Suppl 6):30-6.; (5) Berntorp E, Shapiro A, Astermark J, Blanchette VS, Collins PW, Dimichele D, Escuriola C, Hay CR, Hoots, WK, Leissinger CA, Negrier C, Oldenburg J, Peerlinck K, Reding MT, Hart C. Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia 2006 Dec; 12(Suppl 6):1-7.

 Visit Other Fairview Sites 
(c) 2012 Fairview Health Services. All rights reserved.